UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000020066
Receipt No. R000023177
Official scientific title of the study The observational study on the relations of small bowel endoscopic findings and variability of fecal markers in Crohn's disease
Date of disclosure of the study information 2015/12/04
Last modified on 2018/06/07 (Ver. 11)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The observational study on the relations of small bowel endoscopic findings and variability of fecal markers in Crohn's disease
Title of the study (Brief title) The observational study on the relations of small bowel endoscopic findings and fecal markers in Crohn's disease
Region
Japan

Condition
Condition Crohn's disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the usefulness of endoscopic findings and variability of fecal calprotectin in Crohn's disease
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes To compare fecal calprotectin with or without small-intestinal and colorectal lesion
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patient aged 20 and more who planned double-ballon endoscopy for the suspected crohn's disease
Key exclusion criteria 1)Patients with acute abdomen
2)Patients with severe acute inflammation
3)pregnant patients
4)Patients in a very bad general condition
5)Patients having severe blood clotting defect
6)Patients who have participated in same clinical trials
7)Patients, the investigator (or the subinvestigator) considers, inappropriate for entry into the trial
Target sample size 50

Research contact person
Name of lead principal investigator Watanabe Osamu
Organization Nagoya University Hospital
Division name Department of Gastroenterology and Hepatology
Address 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan
TEL 052-744-2172
Email osa-wata@med.nagoya-u.ac.jp

Public contact
Name of contact person Masanao Nakamura
Organization Nagoya University Hospital
Division name Department of Gastroenterology and Hepatology
Address 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan
TEL 052-744-2172
Homepage URL
Email makamura@med.nagoya-u.ac.jp

Sponsor
Institute Nagoya University Hospital
Institute
Department

Funding Source
Organization Nagoya University Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 04 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 12 Month 03 Day
Anticipated trial start date
2016 Year 01 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Measurements;
Endoscopic findings/blood exam(red blood cells, white blood cells, hemogram, platelets, amylase, C-reactive protein, hepatobiliary system enzyme, lactase dehydrogenase, blood urea nitrogen, creatinine, total protein, albumin, erythrocyte sedimentation rate)/fecal calprotectin,immunological fecal occult blood test/IOIBD(International Organization for the Study of Inflammatory Bowel Disease)/CDAI(Crohn's Disease Activity Index)/histopathological findings

Management information
Registered date
2015 Year 12 Month 03 Day
Last modified on
2018 Year 06 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023177